Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17640 | 589 | 43.5 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
566 | 2 | EPOXYEICOSATRIENOIC ACIDS//LIPOXYGENASE//LEUKOTRIENES | 14430 |
17640 | 1 | 12S HETE//LY293111//ZYFLAMEND | 589 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | 12S HETE | authKW | 338683 | 2% | 47% | 14 |
2 | LY293111 | authKW | 331782 | 1% | 80% | 8 |
3 | ZYFLAMEND | authKW | 207366 | 1% | 100% | 4 |
4 | 12 LIPOXYGENASE | authKW | 191679 | 4% | 15% | 25 |
5 | BIOMIDE S | address | 155525 | 1% | 100% | 3 |
6 | CYSLT2R | authKW | 138241 | 1% | 67% | 4 |
7 | 5 LIPOXYGENASE | authKW | 133988 | 8% | 6% | 45 |
8 | MK 886 | authKW | 122361 | 2% | 20% | 12 |
9 | 5 OXOETE | authKW | 103683 | 0% | 100% | 2 |
10 | CYSTEINYLLT1R | authKW | 103683 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 3062 | 38% | 0% | 223 |
2 | Cell Biology | 1062 | 23% | 0% | 135 |
3 | Biochemistry & Molecular Biology | 754 | 32% | 0% | 189 |
4 | Medicine, Research & Experimental | 572 | 13% | 0% | 74 |
5 | Biophysics | 197 | 8% | 0% | 45 |
6 | Endocrinology & Metabolism | 102 | 6% | 0% | 37 |
7 | Pharmacology & Pharmacy | 33 | 7% | 0% | 42 |
8 | Gastroenterology & Hepatology | 32 | 3% | 0% | 18 |
9 | Biology | 20 | 2% | 0% | 14 |
10 | Physiology | 17 | 3% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOMIDE S | 155525 | 1% | 100% | 3 |
2 | GASTROINTESTINAL ONCOL S | 103683 | 0% | 100% | 2 |
3 | CELL EXPT PATHOL | 80995 | 1% | 31% | 5 |
4 | LUMINAL GASTROENTEROL | 69121 | 0% | 67% | 2 |
5 | GERSHENSON RADIAT ONCOL | 60842 | 2% | 13% | 9 |
6 | PATHOL EXPTL CANC 1 | 58318 | 1% | 38% | 3 |
7 | ALLGEMEINCHIRURG VISCERALCHIRURG | 51842 | 0% | 100% | 1 |
8 | ANIM PHYSIOL GEN ZOOL | 51842 | 0% | 100% | 1 |
9 | BIOCHEM BIONFORMAT | 51842 | 0% | 100% | 1 |
10 | BIOTECHNOL BIOCHEM MICROBIOL | 51842 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 7307 | 4% | 1% | 21 |
2 | ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY | 3173 | 5% | 0% | 32 |
3 | CANCER PREVENTION RESEARCH | 2699 | 1% | 1% | 8 |
4 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 1824 | 1% | 0% | 8 |
5 | EXPERIMENTAL CELL RESEARCH | 894 | 3% | 0% | 15 |
6 | INTERNATIONAL JOURNAL OF CANCER | 807 | 3% | 0% | 18 |
7 | CANCER AND METASTASIS REVIEWS | 674 | 1% | 0% | 4 |
8 | CLINICAL PHYSIOLOGY AND BIOCHEMISTRY | 650 | 0% | 1% | 2 |
9 | CANCER RESEARCH | 611 | 4% | 0% | 22 |
10 | VETERINARY AND COMPARATIVE ONCOLOGY | 569 | 0% | 1% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 12S HETE | 338683 | 2% | 47% | 14 | Search 12S+HETE | Search 12S+HETE |
2 | LY293111 | 331782 | 1% | 80% | 8 | Search LY293111 | Search LY293111 |
3 | ZYFLAMEND | 207366 | 1% | 100% | 4 | Search ZYFLAMEND | Search ZYFLAMEND |
4 | 12 LIPOXYGENASE | 191679 | 4% | 15% | 25 | Search 12+LIPOXYGENASE | Search 12+LIPOXYGENASE |
5 | CYSLT2R | 138241 | 1% | 67% | 4 | Search CYSLT2R | Search CYSLT2R |
6 | 5 LIPOXYGENASE | 133988 | 8% | 6% | 45 | Search 5+LIPOXYGENASE | Search 5+LIPOXYGENASE |
7 | MK 886 | 122361 | 2% | 20% | 12 | Search MK+886 | Search MK+886 |
8 | 5 OXOETE | 103683 | 0% | 100% | 2 | Search 5+OXOETE | Search 5+OXOETE |
9 | CYSTEINYLLT1R | 103683 | 0% | 100% | 2 | Search CYSTEINYLLT1R | Search CYSTEINYLLT1R |
10 | CYSTEINYLLT1R ANTAGONIST | 103683 | 0% | 100% | 2 | Search CYSTEINYLLT1R+ANTAGONIST | Search CYSTEINYLLT1R+ANTAGONIST |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | STEINHILBER, D , FISCHER, AS , METZNER, J , STEINBRINK, SD , ROOS, J , RUTHARDT, M , MAIER, TJ , (2010) 5-LIPOXYGENASE: UNDERAPPRECIATED ROLE OF A PRO-INFLAMMATORY ENZYME IN TUMORIGENESIS.FRONTIERS IN PHARMACOLOGY. VOL. 1. ISSUE . P. - | 38 | 58% | 10 |
2 | MELSTROM, LG , BENTREM, DJ , SALABAT, MR , KENNEDY, TJ , DING, XZ , STROUCH, M , RAO, SM , WITT, RC , TERNENT, CA , TALAMONTI, MS , ET AL (2008) OVEREXPRESSION OF 5-LIPOXYGENASE IN COLON POLYPS AND CANCER AND THE EFFECT OF 5-LOX INHIBITORS IN VITRO AND IN A MURINE MODEL.CLINICAL CANCER RESEARCH. VOL. 14. ISSUE 20. P. 6525-6530 | 27 | 77% | 61 |
3 | CHEN, XX , SOOD, S , YANG, CS , LI, N , SUN, Z , (2006) FIVE-LIPOXYGENASE PATHWAY OF ARACHIDONIC ACID METABOLISM IN CARCINOGENESIS AND CANCER CHEMOPREVENTION.CURRENT CANCER DRUG TARGETS. VOL. 6. ISSUE 7. P. 613-622 | 52 | 33% | 34 |
4 | GUO, YD , ZHANG, WL , GIROUX, C , CAI, YL , EKAMBARAM, P , DILLY, AK , HSU, A , ZHOU, SL , MADDIPATI, KR , LIU, JJ , ET AL (2011) IDENTIFICATION OF THE ORPHAN G PROTEIN-COUPLED RECEPTOR GPR31 AS A RECEPTOR FOR 12-(S)-HYDROXYEICOSATETRAENOIC ACID.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 286. ISSUE 39. P. 33832-33840 | 21 | 66% | 43 |
5 | DILLY, AK , EKAMBARAM, P , GUO, YD , CAI, YL , TUCKER, SC , FRIDMAN, R , KANDOUZ, M , HONN, KV , (2013) PLATELET-TYPE 12-LIPOXYGENASE INDUCES MMP9 EXPRESSION AND CELLULAR INVASION VIA ACTIVATION OF PI3K/AKT/NF-B.INTERNATIONAL JOURNAL OF CANCER. VOL. 133. ISSUE 8. P. 1784-1791 | 18 | 67% | 19 |
6 | MORENO, JJ , (2009) NEW ASPECTS OF THE ROLE OF HYDROXYEICOSATETRAENOIC ACIDS IN CELL GROWTH AND CANCER DEVELOPMENT.BIOCHEMICAL PHARMACOLOGY. VOL. 77. ISSUE 1. P. 1-10 | 33 | 33% | 77 |
7 | YOSHIMURA, R , INOUE, K , KAWAHITO, Y , MITSUHASHI, M , TSUCHIDA, K , MATSUYAMA, M , SANO, H , NAKATANI, T , (2004) EXPRESSION OF 12-LIPOXYGENASE IN HUMAN RENAL CELL CARCINOMA AND GROWTH PREVENTION BY ITS INHIBITOR.INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. VOL. 13. ISSUE 1. P. 41-46 | 18 | 78% | 22 |
8 | XU, XM , DENG, JJ , YUAN, GJ , YANG, F , GUO, HT , XIANG, M , GE, W , WU, YG , (2011) 5-LIPOXYGENASE CONTRIBUTES TO THE PROGRESSION OF HEPATOCELLULAR CARCINOMA.MOLECULAR MEDICINE REPORTS. VOL. 4. ISSUE 6. P. 1195-1200 | 16 | 70% | 5 |
9 | ZHOU, GX , DING, XL , WU, SB , ZHANG, HF , CAO, W , QU, LS , ZHANG, H , (2015) INHIBITION OF 5-LIPOXYGENASE TRIGGERS APOPTOSIS IN PANCREATIC CANCER CELLS.ONCOLOGY REPORTS. VOL. 33. ISSUE 2. P. 661 -668 | 18 | 53% | 3 |
10 | HONN, KV , GUO, YD , CAI, YL , LEE, MJ , DYSON, G , ZHANG, WL , TUCKER, SC , (2016) 12-HETER1/GPR31, A HIGH-AFFINITY 12(S)-HYDROXYEICOSATETRAENOIC ACID RECEPTOR, IS SIGNIFICANTLY UP-REGULATED IN PROSTATE CANCER AND PLAYS A CRITICAL ROLE IN PROSTATE CANCER PROGRESSION.FASEB JOURNAL. VOL. 30. ISSUE 6. P. 2360 -2369 | 25 | 38% | 0 |
Classes with closest relation at Level 1 |